World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
26412
World Ranking
14615
National Ranking
210

Inti Zlobec publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Inti Zlobec sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 376 publications — 33rd percentile

33% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Inti Zlobec D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Inti Zlobec sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Inti Zlobec is affiliated with the University of Bern in Switzerland and has a research focus primarily within the field of Medicine, with extensive work in Oncology, Radiology, Nuclear Medicine and Imaging, Artificial Intelligence, Immunology, and Molecular Biology.

The scientist's research topics include Radiomics and Machine Learning in Medical Imaging, AI in cancer detection, Cancer Immunotherapy and Biomarkers, Colorectal Cancer Screening and Detection, Colorectal Cancer Surgical Treatments, Colorectal Cancer Treatments and Studies, and Cancer Cells and Metastasis.

Recent publications by Inti Zlobec include:

  • Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front, 2020, Cell
  • Tumour budding in solid cancers, 2020, Nature Reviews Clinical Oncology
  • Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer, 2020, Journal of Clinical Oncology
  • Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front, 2020, Cell
  • A Consensus-Developed Morphological Re-Evaluation of 196 High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms and Its Clinical Correlations, 2020, Neuroendocrinology

Frequent co-authors collaborating with Inti Zlobec include:

  • Alessandro Lugli
  • Heather Dawson
  • Irıs D. Nagtegaal
  • Martin D. Berger
  • Eva Karamitopoulou

Key publication venues for Zlobec's work consist of:

  • Bern Open Repository and Information System (University of Bern)
  • Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
  • Modern Pathology
  • Cancer Research
  • Zenodo (CERN European Organization for Nuclear Research)

Best Publications

  • International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

    Franck Pagès;Bernhard Mlecnik;Florence Marliot;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea

  • Towards the introduction of the 'Immunoscore' in the classification of malignant tumours.

    Jérôme Galon;Jérôme Galon;Jérôme Galon;Bernhard Mlecnik;Bernhard Mlecnik;Bernhard Mlecnik;Gabriela Bindea;Gabriela Bindea;Gabriela Bindea;Helen K. Angell;Helen K. Angell;Helen K. Angell

  • Cancer classification using the Immunoscore: a worldwide task force

    Jérôme Galon;Franck Pagès;Francesco M Marincola;Francesco M Marincola;Helen K Angell;Helen K Angell

  • Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

    Alessandro Lugli;Richard Kirsch;Yoichi Ajioka;Fred Bosman

  • Coordinated Cellular Neighborhoods Orchestrate Antitumoral Immunity at the Colorectal Cancer Invasive Front.

    Christian M. Schürch;Salil S. Bhate;Graham L. Barlow;Darci J. Phillips

  • Clinical impact of programmed cell death ligand 1 expression in colorectal cancer.

    Raoul A. Droeser;Raoul A. Droeser;Christian Hirt;Christian Hirt;Carsten T. Viehl;Daniel M. Frey

  • Synaptic proximity enables NMDAR signalling to promote brain metastasis

    Qiqun Zeng;Iacovos P. Michael;Peng Zhang;Sadegh Saghafinia

  • High frequency of tumor‐infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair‐proficient colorectal cancer patients

    Daniel M. Frey;Raoul A. Droeser;Carsten T. Viehl;Inti Zlobec

  • Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer

    A Lugli;G Iezzi;I Hostettler;M G Muraro

  • Epithelial mesenchymal transition and tumor budding in aggressive colorectal cancer: Tumor budding as oncotarget

    Inti Zlobec;Alessandro Lugli

  • Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a ‘fusion’ pathway to colorectal cancer

    J R Jass;K Baker;I Zlobec;T Higuchi;T Higuchi

  • Prognostic and predictive factors in colorectal cancer

    Inti Zlobec;Alessandro Lugli

  • Clinicopathological and protein characterization of BRAF- and K-RAS-mutated colorectal cancer and implications for prognosis.

    Inti Zlobec;Michel P. Bihl;Heike Schwarb;Luigi Terracciano

  • Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study

    Enric Domingo;Enric Domingo;Luke Freeman-Mills;Emily Rayner;Mark Glaire

  • Tumor budding in colorectal cancer—ready for diagnostic practice?

    Viktor H. Koelzer;Inti Zlobec;Alessandro Lugli

  • Characterization of rectal, proximal and distal colon cancers based on clinicopathological, molecular and protein profiles

    P. Minoo;I. Zlobec;M. Peterson;L. Terracciano

  • Is the improved prognosis of p16 positive oropharyngeal squamous cell carcinoma dependent of the treatment modality

    Claude A. Fischer;Inti Zlobec;Edith Green;Simone Probst

  • Tumour budding in solid cancers

    Alessandro Lugli;Inti Zlobec;Martin D Berger;Richard Kirsch

  • Selecting immunohistochemical cut‐off scores for novel biomarkers of progression and survival in colorectal cancer

    Inti Zlobec;Russell Steele;Luigi Terracciano;Jeremy R Jass

  • Tumour budding: a promising parameter in colorectal cancer

    A Lugli;Eva Karamitopoulou;I Zlobec

Frequent Co-Authors

Alessandro Lugli
Alessandro Lugli University of Bern
Luigi Terracciano
Luigi Terracciano University Hospital of Basel
Aurel Perren
Aurel Perren University of Bern
Lukas Bubendorf
Lukas Bubendorf University Hospital of Basel
Jeremy R. Jass
Jeremy R. Jass Imperial College London
Arndt Hartmann
Arndt Hartmann University of Erlangen-Nuremberg
Iris D. Nagtegaal
Iris D. Nagtegaal Radboud University
Giulio C. Spagnoli
Giulio C. Spagnoli University Hospital of Basel
George N. Thalmann
George N. Thalmann University of Bern

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine opens doors to diverse online degree options beyond traditional MD programs. Many healthcare professionals are choosing flexible online learning to support their careers, whether in clinical settings or healthcare administration.

For those interested in leadership and management, evaluating the cost of mha degree is an essential step toward a career in healthcare administration. Nursing professionals looking for advanced practice can consider msn to dnp programs online, which provide a pathway to the Doctor of Nursing Practice from a Master’s in Nursing.

Pharmacists can also benefit from flexible study options, such as a 3 year online pharmd program, which enables students to qualify as a Doctor of Pharmacy without putting their careers on pause. Additionally, the rapid growth of health data has boosted demand for graduates with a health information technology online degree, preparing professionals to manage and protect critical healthcare information.

Each of these online pathways offers flexibility, affordability, and specialized career potential within the evolving healthcare industry.

Best Scientists Citing Inti Zlobec

Trending Scientists